AzTrials
AzTrials

Trauma and Emergency CarePERMIT-LATAMNCT07530653

Delayed Fluids in Hemorrhagic Shock Due to Severe Injuries.

An observational study of Trauma and Emergency Care and Shock,Hemorrhagic, run by Hospital Departamental de Villavicencio at 1 site in Colombia.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

This study will provide information on the quality of care in hemorrhagic shock of severe injuries in a limited resource facility of Latin America, the strategies of fluid resuscitation, and outcomes. Read more about this study

Who is it for?
Ages 18 to 100 years
What is being tested?
Crystalloid below 1000 mL. and IV fluids more than 1,000 mL
Type of treatment
Injection or infusion
How many people
716 participants
Where
1 siteColombia
Study dates
1 Oct 2026to 30 Nov 2028
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 100 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Hypotensive patients in the emergency department or prehospital care caused by penetrating or blunt injuries.

Who may be able to join

  • Major injuries.
  • ISS >15.
  • Hypotension with a systolic blood pressure below 90 mmHg.
  • No previous hospital care.
  • Older than 16 years.

Who cannot join

  • Brain injuries.
  • Pregnancy.
  • Drowning.
  • Burns.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Emma I Rodriguez Darabos, MSc contact

3112517538

emmaisa1@hotmail.com

Colombia1 site
  • Hospital Departamental de Villavicencio

    Villavicencio, Meta Department, 50001

    Norton Perez, MD, 3112517471, norton.perez@hotmail.com

    Emma Rodriguez Darabos, MSc, norton.perez@hotmail.com

Other trials in Colombia

About this study

Official title: Delayed Resuscitation in Hemorrhagic Shock Due to Severe Injuries of the Torso in Low-resource Facilities of Latin America.

This study will provide information on the quality of care in hemorrhagic shock of severe injuries in a limited resource facility of Latin America, the strategies of fluid resuscitation, and outcomes.

Read the detailed description

Background / Introduction

Trauma remains a leading cause of mortality worldwide, particularly among young and economically productive populations, generating a disproportionate burden in terms of years of life lost, disability, and healthcare expenditures. Hemorrhagic shock is the most common cause of preventable death following trauma, especially within the first hours after injury. Despite advances in trauma systems and critical care, early mortality due to uncontrolled bleeding continues to pose a major clinical challenge.

Traditional resuscitation strategies have emphasized aggressive early fluid administration aimed at restoring normotension. However, growing evidence suggests that this approach may be physiologically detrimental in the setting of uncontrolled hemorrhage. Rapid volume expansion can dislodge forming clots, dilute coagulation factors, exacerbate acidosis, and contribute to the development of trauma-induced coagulopathy. These mechanisms are closely associated with the so-called "lethal triad" of trauma: hypothermia, acidosis, and coagulopathy, which significantly increases mortality risk.

In response to these concerns, the concept of delayed resuscitation, also referred to as permissive hypotension, has emerged as a damage control strategy. This approach aims to limit fluid administration until hemorrhage control is achieved, maintaining a lower-than-normal blood pressure sufficient for minimal organ perfusion while avoiding exacerbation of bleeding. Experimental models and clinical studies have suggested potential benefits, including reduced blood loss, lower transfusion requirements, and improved survival in selected patient populations.

However, the current body of evidence presents important limitations. Many studies have been conducted in high-resource settings with well-developed trauma systems, rapid surgical access, and availability of blood products. Furthermore, heterogeneity in study design, patient populations, injury patterns, and resuscitation protocols limits the generalizability of findings. Importantly, patients with traumatic brain injury, elderly individuals, and those with significant comorbidities may respond differently to hypotensive strategies, raising concerns regarding safety and applicability.

These uncertainties are particularly relevant in low- and middle-income countries (LMICs), including those in Latin America, where the burden of trauma is disproportionately high and healthcare systems often face resource constraints. In such settings, delays in definitive hemorrhage control, limited access to blood products, variability in prehospital care, and constrained intensive care capacity may influence both the feasibility and effectiveness of resuscitation strategies. Consequently, there is a critical need for context-specific evidence to guide clinical decision-making and optimize trauma care protocols in these environments.

Objective

To compare clinical outcomes in patients with hemorrhagic shock due to severe trauma according to the initial fluid resuscitation strategy, specifically delayed (permissive hypotension) versus immediate (conventional) resuscitation, in low-resource healthcare settings in Latin America.

Methods Study Design

This study is designed as a prospective, observational, analytical cohort study conducted in one or more tertiary-level trauma centers in Latin America. The study will adhere to STROBE guidelines for observational research.

Study Population

Eligible participants will include adult patients (≥18 years) presenting with severe trauma and clinical evidence of hemorrhagic shock. Hemorrhagic shock will be defined using a combination of clinical and laboratory criteria, including systolic blood pressure <90 mmHg, elevated lactate levels, base deficit, and/or clinical signs of hypoperfusion.

Inclusion Criteria Adult patients with major trauma (Injury Severity Score ≥15) Evidence of active bleeding or suspected hemorrhagic shock Admission within a defined time window from injury Exclusion Criteria Severe traumatic brain injury requiring strict blood pressure targets Cardiac arrest prior to hospital arrival Pregnant patients Patients with advanced directives limiting care Exposure Definition

Patients will be categorized based on the initial resuscitation strategy:

Delayed resuscitation group: restricted fluid administration prior to hemorrhage control, targeting permissive hypotension (e.g., systolic blood pressure 80-90 mmHg or presence of radial pulse) Immediate resuscitation group: standard aggressive fluid resuscitation aiming to restore normotension Data Collection

Data will be collected prospectively using standardized case report forms and will include:

Demographic characteristics Mechanism and severity of injury Prehospital and emergency department interventions Hemodynamic parameters and laboratory values Volume of fluids and blood products administered Time to hemorrhage control Outcomes Primary Outcome In-hospital mortality Secondary Outcomes 24-hour mortality Blood product utilization Development of complications (e.g., acute respiratory distress syndrome, multiple organ dysfunction syndrome, acute kidney injury) Length of stay in intensive care unit and hospital Need for surgical or interventional procedures Statistical Analysis

Descriptive statistics will be used to summarize baseline characteristics. Comparisons between groups will be performed using appropriate statistical tests (Chi-square, t-test, or Mann-Whitney U test). Multivariable logistic regression models will be constructed to evaluate the association between resuscitation strategy and outcomes, adjusting for potential confounders such as injury severity, age, mechanism of trauma, and comorbidities.

Propensity score methods may be employed to reduce selection bias and improve comparability between groups. Sensitivity analyses will be conducted to assess robustness of findings.

Expected Results

It is hypothesized that delayed resuscitation will be associated with:

Reduced in-hospital mortality Lower transfusion requirements Decreased incidence of complications related to fluid overload and coagulopathy

However, potential risks, including inadequate organ perfusion and adverse outcomes in specific subgroups, will also be critically evaluated.

Being tested
Crystalloid below 1000 mL., IV fluids more than 1,000 mL
Keywords
Severe Trauma, Hemorrhagic shock, Non-compresible torso injuries, Delayes resuscitation, Permissive hypotension, IV fluids, Low-resource settings, Latin America, Trauma systems
Medical subject headings
Wounds and Injuries, Shock, Hemorrhagic

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Crystalloid below 1000 mL.Drug

    Also called Restricted IV fluids, Permissive hypotension

    Administration of IV fluids below 1,000 mL on prehospital care.

  • IV fluids more than 1,000 mLDrug

    Also called High volume resuscitation

    Prehospital IV fluids more than 1,000 mL.

Study groups in NCT07530653
Study groupRoleWhat they receive
Delayed resuscitationIV fluids lower than 1000 mL.
Receives: Drug: Crystalloid below 1000 mL.
Immediate resuscitationIV fluids > 1000 mL
Receives: Drug: IV fluids more than 1,000 mL

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. In-hospital mortality

    Mortality on discharge or before 28 days.

    Measured: 28 days

Secondary outcomes (2)
  1. Early mortality

    Mortality in the ICU or within 24 hours of admission.

    Measured: 24 hours.

  2. Coagulopathy

    Bleeding times prolonged > 1.5 times.

    Measured: 24 hours.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted15 Apr 2026
  2. Study start1 Oct 2026 (estimated)
  3. Primary completion30 Sep 2028 (estimated)
  4. Study completion30 Nov 2028 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Retrospective
Enrolment
716 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07530653
Sponsor's protocol ID
GRIVI_2026_01_TMA_RESUSC
Acronym
PERMIT-LATAM
Status last verified
May 2026
First submitted
9 Apr 2026
Last updated
28 May 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: Patient's information included.

Publications

  • Deeb AP, Lu L, Guyette FX, Peitzman AB, Daley BJ, Miller RS, Harbrecht BG, Phelan HA, Sperry JL, Brown JB. Optimal Prehospital Crystalloid Resuscitation Volume in Trauma Patients at Risk for Hemorrhagic Shock. J Am Coll Surg. 2023 Aug 1;237(2):183-194. doi: 10.1097/XCS.0000000000000695. Epub 2023 Mar 28.

    PubMed 36975122
  • Bernhardt IM, Moore EE, Sauaia A, Cotton BA, Cannon JW, Schreiber MA, Namias N, Minei JP, Wisniewski SR, Guyette FX, Sperry JL; Shock, Whole Blood, and Assessment of Traumatic Brain Injury (SWAT) Study Group. Timing of trauma deaths due to uncontrolled bleeding have not changed in three decades: A multicenter study of patients in hemorrhagic shock. Am J Surg. 2025 Dec;250:116510. doi: 10.1016/j.amjsurg.2025.116510. Epub 2025 Jul 8.

    PubMed 40706451
  • Pinsky MR. The Effective Management of Shock: Moving From Physiology to Guidelines to Personalized Medicine. Crit Care Med. 2026 Jun 1;54(6):1495-1502. doi: 10.1097/CCM.0000000000007115. Epub 2026 Mar 17.

    PubMed 41841954
  • Penn J, McAleer R, Ziegler C, Cheskes S, Nolan B, von Vopelius-Feldt J. Effectiveness of Prehospital Critical Care Scene Response for Major Trauma: A Systematic Review. Prehosp Emerg Care. 2026;30(2):309-322. doi: 10.1080/10903127.2025.2483978. Epub 2025 Apr 1.

    PubMed 40131291
  • Gnanou S, Guertin JR, Tardif PA, Conombo B, Berube M, Yanchar N, Berthelot S, Gnanvi J, Moore L. Cost-effectiveness of specialized trauma care: A systematic review. J Health Serv Res Policy. 2026 Jan;31(1):56-67. doi: 10.1177/13558196251348409. Epub 2025 Jun 4.

    PubMed 40464624
  • Bickell WH, Wall MJ Jr, Pepe PE, Martin RR, Ginger VF, Allen MK, Mattox KL. Immediate versus delayed fluid resuscitation for hypotensive patients with penetrating torso injuries. N Engl J Med. 1994 Oct 27;331(17):1105-9. doi: 10.1056/NEJM199410273311701.

    PubMed 7935634

Questions about this trial

What is this clinical trial studying?

An observational study of Trauma and Emergency Care and Shock,Hemorrhagic, run by Hospital Departamental de Villavicencio at 1 site in Colombia.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 28 May 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Colombia. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Norton Perez, MD (+573112517471, norton.perez@hotmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

In-hospital mortality (time frame: 28 days). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07530653, which also lists 6 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 May 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in